As of June 18, 2026, Fate Therapeutics's top three insider holders are Group, Llc Redmile (Director, 13.18Mn shares), Group, Llc Redmile (Director, 12.97Mn shares), Group, Llc Redmile (Director, 12.88Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| William H Rastetter | - | 11,331 | 0 | 13 Jun, 2022 |
| Timothy Coughlin | - | 9,892 | 0 | 13 Jun, 2022 |
| Group, Llc Redmile | - | 0 | 13,180,388 | 28 Dec, 2023 |
| J Scott Wolchko | President And Ceo | 371,248 | 0 | 10 Jan, 2024 |
| Cindy Tahl | General Counsel And Secretary | 487,081 | 0 | 16 Jan, 2026 |
| Shefali Agarwal | - | 10,490 | 0 | 13 Jun, 2022 |
| Michael Stewart Lee | - | 11,331 | 0 | 13 Jun, 2022 |
| Bahram Valamehr | President And Ceo | 664,708 | 0 | 16 Jan, 2026 |
| Karin Jooss | - | 9,848 | 0 | 13 Jun, 2022 |
| Kamal Adawi | Chief Financial Officer | 100,000 | 0 | 16 Jan, 2026 |
| Edward J Iii Dulac | Chief Financial Officer | 101,479 | 0 | 05 Mar, 2024 |
| Yu-Waye Chu | Chief Medical Officer | 140,676 | 0 | 19 Apr, 2023 |
| Yuan Xu | - | 8,669 | 0 | 07 Aug, 2024 |
| Mark Plavsic | Chief Technical Officer | 123,705 | 0 | 11 Jan, 2023 |
| Brian T. Powl | Chief Commercial Officer | 41,146 | 0 | 06 Jul, 2023 |
| Jerome Charles Bressi | - | 335,203 | 0 | 16 Jan, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Apr, 2026 | Group, Llc Redmile | Common Stock | D | 8,977,624 | $0.00 | 0 | D | J |
| 20 Apr, 2026 | Group, Llc Redmile | Common Stock | A | 8,977,624 | $0.00 | 12,884,277 | I | J |
| 20 Apr, 2026 | Group, Llc Redmile | Pre-Funded Warrants to Purchase Common Stock | D | 3,691,324 | $0.00 | 0 | D | J |
| 20 Apr, 2026 | Group, Llc Redmile | Pre-Funded Warrants to Purchase Common Stock | A | 3,691,324 | $0.00 | 3,893,674 | I | J |
| 20 Apr, 2026 | Group, Llc Redmile | Cash-settled Swaps | D | 266,280 | $0.00 | 0 | D | J |
| 20 Apr, 2026 | Group, Llc Redmile | Cash-settled Swaps | A | 266,280 | $0.00 | 502,769 | I | J |
| 20 Apr, 2026 | Group, Llc Redmile | Class A Convertible Preferred Stock | D | 162,013 | $0.00 | 0 | D | J |
| 20 Apr, 2026 | Group, Llc Redmile | Class A Convertible Preferred Stock | A | 162,013 | $0.00 | 2,755,086 | I | J |
| 15 Jan, 2026 | Cindy Tahl | Common Stock | A | 100,000 | $0.00 | 487,081 | D | A |
| 15 Jan, 2026 | Bahram Valamehr | Common Stock | A | 335,000 | $0.00 | 664,708 | D | A |
| 15 Jan, 2026 | Bahram Valamehr | Common Stock | A | 335,000 | $0.00 | 664,708 | D | A |
| 15 Jan, 2026 | Cindy Tahl | Common Stock | A | 100,000 | $0.00 | 487,081 | D | A |
| 15 Jan, 2026 | Bahram Valamehr | Common Stock | A | 335,000 | $0.00 | 664,708 | D | A |
| 15 Jan, 2026 | Kamal Adawi | Common Stock | A | 25,000 | $0.00 | 100,000 | D | A |
| 15 Jan, 2026 | Cindy Tahl | Common Stock | A | 100,000 | $0.00 | 487,081 | D | A |
| 15 Jan, 2026 | Cindy Tahl | Stock Option (Right to Buy) | A | 400,000 | $0.00 | 400,000 | D | A |
| 15 Jan, 2026 | Bahram Valamehr | Stock Option (Right to Buy) | A | 1,300,000 | $0.00 | 1,300,000 | D | A |
| 15 Jan, 2026 | Cindy Tahl | Stock Option (Right to Buy) | A | 400,000 | $0.00 | 400,000 | D | A |
| 15 Jan, 2026 | Bahram Valamehr | Stock Option (Right to Buy) | A | 1,300,000 | $0.00 | 1,300,000 | D | A |
| 15 Jan, 2026 | Bahram Valamehr | Stock Option (Right to Buy) | A | 1,300,000 | $0.00 | 1,300,000 | D | A |